2016 VAM: 1001 - Allergen Immunotherapy, Today and Tomorrow: Session I. Inhalant Allergens for Allergic Rhinitis and Asthma

The course will summarize state of the art of allergen immunotherapy for asthma and allergic rhinitis, including new observations on immunologic changes associated with immunotherapy, and will include a special emphasis on inducing tolerance to inhalant allergens.

AMA PRA Category 1 Credits™: 2.50
CE: 2.50

Credit must be claimed by May 31, 2018.  Any credit request on or after June 1, 2018 will be subject to an administrative fee.

Target Audience

Nurse Practitioners
Allied Health Professionals

Learning Objectives

Upon completion of this activity, participants should be able to:
1.  Discuss current and future approaches to allergen immunotherapy for asthma and allergic rhinitis
2.  Discuss the potential mechanisms by which immunotherapy modulates the immune response to allergens
3.  Discuss the durability of immune unresponsiveness induced by allergen immunotherapy



Additional Information

PDF icon 2016 Annual Meeting Disclosures120.13 KB
Available credit: 
  • 2.50 Attendance
    Attendance credit.
  • 2.50 CE
    CE credit.
  • 2.50 CME
    CME credit.
Course opens: 
Course expires: 
Dr. Alessandro Sette, Dr. Biol. Sci. and Dr. Bjoern Peters, PhD, La Jolla Institute for Allergy and Immunology, La Jolla, CA
Relevant relationships: ALK-Abello (Ongoing): Consultant
Dr. Erik R. Wambre, PhD MBE, Benaroya Research Institute, Seattle, WA
Relevant relationships: None
Dr. Mark Larché, PhD, McMaster University/St. Joseph's Healthcare, Hamilton, ON, Canada
Relevant relationships: Adiga Life Sciences (Ongoing): Consultant, NIH (Ongoing): U19 collaborative agreement. Partial salary support Canadian Institutes for Health Research:Operating grant. No salary support McMaster University/GSK Chair in Lung Immunology at St. Joseph's Healthcare (Ongoing): Endowed Chair. No salary support. Abbott (Ongoing): Spouse investigator initiated study in rheumatoid arthritis Adiga Life Sciences (Ongoing): Research Contracts Canada Research Chair (Ongoing): Partial Salary award. Circassia Pharmaceuticals (Ongoing): Stock World Allergy Organization (Ongoing): co-Chair Immunotherapy and Immunomodulation Committee

Dr. Tolly Epstein, MD MS FAAAAI, University of Cincinnati Division of Immunology, Allergy, & Rheumatology, Cincinnati, OH  Relevant relationships: None

Annual Meeting sessions and faculty were reviewed by members of the Practice Improvement Subcommittee.  Disclosures are located in the 2016 Annual Meeting Disclosures PDF. 

Available Credit

  • 2.50 Attendance
    Attendance credit.
  • 2.50 CE
    CE credit.
  • 2.50 CME
    CME credit.


Please login or register to take this course.

Required Hardware/software

Our system supports the two most recent versions of Safari, Google Chrome, and Firefox. Internet Explorer is not recommended.